243 related articles for article (PubMed ID: 30608429)
21. CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
Kuzmina Z; Krenn K; Petkov V; Körmöczi U; Weigl R; Rottal A; Kalhs P; Mitterbauer M; Ponhold L; Dekan G; Greinix HT; Pickl WF
Blood; 2013 Mar; 121(10):1886-95. PubMed ID: 23303823
[TBL] [Abstract][Full Text] [Related]
22. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience.
Jung HS; Lee JG; Yu WS; Lee CY; Haam SJ; Paik HC
Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):914-918. PubMed ID: 27481680
[TBL] [Abstract][Full Text] [Related]
23. Late pulmonary complications after allogeneic hematopoietic stem cell transplantation: diagnosis, monitoring, prevention, and treatment.
Bacigalupo A; Chien J; Barisione G; Pavletic S
Semin Hematol; 2012 Jan; 49(1):15-24. PubMed ID: 22221781
[TBL] [Abstract][Full Text] [Related]
24. Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Galbán CJ; Boes JL; Bule M; Kitko CL; Couriel DR; Johnson TD; Lama V; Telenga ED; van den Berge M; Rehemtulla A; Kazerooni EA; Ponkowski MJ; Ross BD; Yanik GA
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1592-8. PubMed ID: 24954547
[TBL] [Abstract][Full Text] [Related]
25. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis.
Bergeron A; Godet C; Chevret S; Lorillon G; Peffault de Latour R; de Revel T; Robin M; Ribaud P; Socié G; Tazi A
Bone Marrow Transplant; 2013 Jun; 48(6):819-24. PubMed ID: 23208317
[TBL] [Abstract][Full Text] [Related]
26. A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms.
Kordjazy N; Amini S
Ther Adv Respir Dis; 2024; 18():17534666241232284. PubMed ID: 38504551
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
Nakane T; Nakamae H; Kamoi H; Koh H; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Ohta K; Terada Y; Koh KR; Yamane T; Hino M
Bone Marrow Transplant; 2008 Jul; 42(1):43-9. PubMed ID: 18347569
[TBL] [Abstract][Full Text] [Related]
28. Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.
Au BK; Au MA; Chien JW
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1072-8. PubMed ID: 21126596
[TBL] [Abstract][Full Text] [Related]
29. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.
Sengsayadeth SM; Srivastava S; Jagasia M; Savani BN
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1479-87. PubMed ID: 22449611
[TBL] [Abstract][Full Text] [Related]
30. Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation.
Moore CA; Pilewski JM; Venkataramanan R; Robinson KM; Morrell MR; Wisniewski SR; Zeevi A; McDyer JF; Ensor CR
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28273385
[TBL] [Abstract][Full Text] [Related]
31. Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
Jamani K; He Q; Liu Y; Davis C; Hubbard J; Schoch G; Lee SJ; Gooley T; Flowers MED; Cheng GS
Biol Blood Marrow Transplant; 2020 May; 26(5):943-948. PubMed ID: 31821885
[TBL] [Abstract][Full Text] [Related]
32. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
[TBL] [Abstract][Full Text] [Related]
33. Value of Screening Spirometry for Early Diagnosis of Bronchiolitis Obliterans Syndrome in Children After Allogeneic Hematopoietic Stem Cell Transplantation.
Yoon JS; Chun YH; Lee JW; Chung NG; Cho B
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e462-7. PubMed ID: 26334431
[TBL] [Abstract][Full Text] [Related]
34. Serum Krebs Von Den Lungen-6 as a Biomarker for Early Detection of Bronchiolitis Obliterans Syndrome in Children Undergoing Allogeneic Stem Cell Transplantation.
Gassas A; Schechter T; Krueger J; Craig-Barnes H; Sung L; Ali M; Dell S; Egeler RM; Zaidman I; Palaniyar N
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1524-8. PubMed ID: 25963919
[TBL] [Abstract][Full Text] [Related]
35. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation.
Alkhunaizi M; Patel B; Bueno L; Bhan N; Ahmed T; Arain MH; Saliba R; Rondon G; Dickey BF; Bashoura L; Ost DE; Li L; Wang S; Shpall E; Champlin RE; Mehta R; Popat UR; Hosing C; Alousi AM; Sheshadri A
Transplant Cell Ther; 2023 Mar; 29(3):204.e1-204.e7. PubMed ID: 36503180
[TBL] [Abstract][Full Text] [Related]
36. Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.
Duque-Afonso J; Ihorst G; Waterhouse M; Zeiser R; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Marks R; Prasse A
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2277-2284. PubMed ID: 29964193
[TBL] [Abstract][Full Text] [Related]
37. Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation.
Sheshadri A; Sacks NC; Healey BE; Raza S; Boerner G; Huang HJ
Clin Ther; 2022 May; 44(5):755-765.e6. PubMed ID: 35513911
[TBL] [Abstract][Full Text] [Related]
38. NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT.
Williams KM; Hnatiuk O; Mitchell SA; Baird K; Gadalla SM; Steinberg SM; Shelhamer J; Carpenter A; Avila D; Taylor T; Grkovic L; Pulanic D; Comis LE; Blacklock-Schuver B; Gress RE; Pavletic SZ
Bone Marrow Transplant; 2014 Apr; 49(4):561-6. PubMed ID: 24419526
[TBL] [Abstract][Full Text] [Related]
39. Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.
Uhlving HH; Andersen CB; Christensen IJ; Gormsen M; Pedersen KD; Buchvald F; Heilmann C; Nielsen KG; Mortensen J; Moser C; Sengeløv H; Müller KG
Biol Blood Marrow Transplant; 2015 Mar; 21(3):531-8. PubMed ID: 25498923
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for bronchiolitis obliterans syndrome in allogeneic hematopoietic stem cell transplantation.
Mo XD; Xu LP; Liu DH; Zhang XH; Chen H; Chen YH; Han W; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
Chin Med J (Engl); 2013 Jul; 126(13):2489-94. PubMed ID: 23823823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
